SCM
ONCS

Stonepine Capital Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Stonepine Capital Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,308
Closed -$452K – 32
2021
Q1 		$452K Buy
+4,308
New +$590K 0.24% 29

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Stonepine Capital Management's ONCS Position: Q2 2021 in Review

Stonepine Capital Management sold out of OncoSec Medical Incorporated (ONCS) in Q2 2021, closing a stake of 4,308 shares — an estimated $452K sold.

Stonepine Capital Management first reported a position in ONCS in Q1 2021 and held it in 1 quarter. The position peaked at $452K in Q1 2021. 35 funds tracked by Wall St. Rank hold ONCS as of Q2 2021.

  • Stonepine Capital Management reported no remaining OncoSec Medical Incorporated position as of Q2 2021 after selling out during the quarter.
  • Stonepine Capital Management sold 4,308 OncoSec Medical Incorporated shares in Q2 2021, an estimated $452K.
  • Stonepine Capital Management first reported a position in OncoSec Medical Incorporated in Q1 2021 and held it in 1 quarter.
  • Stonepine Capital Management's OncoSec Medical Incorporated position peaked at $452K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2021.

Based on Stonepine Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.